Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Evan Sisson, PharmD, MHA, CDE, explains that the most recent guidelines on lipid treatments and therapies are actually from 2004, and that there has been a lot of research since then, so the medical community has been waiting for new guidelines for quite a while. He believes that the new guidelines will shift from a less narrow focus on LDL to a more global look at CV health overall….
More videos with Evan Sisson:
Evan Sisson, PharmD, MHA, CDE, Introduction
Evan Sisson, PharmD, Q2: How Has the Definition of the “Right” Level for LDL Changed?
Evan Sisson, PharmD, Q3: What LDL Level Should Patients Aim For?
Evan Sisson, PharmD, Q4: What Is the Best LDL?
Evan Sisson, PharmD, Q5: Should We Just Add Statins to Our Drinking Water?
Evan Sisson, PharmD, Q6: What Kinds of New Drugs Are in the Pipeline?
Evan Sisson, PharmD, Q7: How Can Lifestyle Affect Statin Use?
Evan Sisson, PharmD, MHA, CDE, is currently an assistant professor at the Virginia Commonwealth University’s School of Pharmacy where he teaches pharmacy, nursing and medical students about drug therapy for hypertension, dyslipidemia and diabetes. His practice settings include a university-based outpatient pharmacotherapy clinic and a local free clinic. In the free clinic, he regularly conducts diabetes education classes.
Sisson is a frequent author. One article was Dyslipidemias: Therapeutic Advances, which appeared in the ACCP Pharmacotherapy Self-Assessment Program used by clinical pharmacists to maintain board certification. Additionally, he authored two AADE publications including AADE’s Quick Guide to Medications and The Diabetes Education Review Guide.
Sisson is very active on the volunteer front. In addition to recently serving on AADE’s Board of Directors, he is a member of Diabetes Forecast magazine’s editorial board and recently served on the National Health Council’s Advisory Board on Patient-Centered Care.
Sisson earned his PharmD and MHA degrees from Virginia Commonwealth University.